Literature DB >> 8279648

Morphologic effects of artemether on Plasmodium falciparum in Aotus trivirgatus.

S Kawai1, S Kano, M Suzuki.   

Abstract

The effects of artemether on the morphology of Plasmodium falciparum were studied in an owl monkey (Aotus trivirgatus) when parasitemia reached 33% and the animal became severely ill. The earliest and the most distinctive ultrastructural changes following the administration of artemether were marked swelling of the mitochondria in the parasites, followed by the appearance of electron-dense chromatin materials in the nuclei and clumping of ribosomes. The initial change was observed within 2 hr of administration of the drug. These findings correlate well with the rapid and effective action of artemether, which has been demonstrated in human clinical trials.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8279648     DOI: 10.4269/ajtmh.1993.49.812

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  15 in total

1.  Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum.

Authors:  Quinton L Fivelman; Ipemida S Adagu; David C Warhurst
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

2.  Ultrastructural and real-time microscopic changes in P. falciparum-infected red blood cells following treatment with antimalarial drugs.

Authors:  Navakanit Sachanonta; Kesinee Chotivanich; Urai Chaisri; Gareth D H Turner; David J P Ferguson; Nicholas P J Day; Emsri Pongponratn
Journal:  Ultrastruct Pathol       Date:  2011-10       Impact factor: 1.094

3.  Identification and validation of tetracyclic benzothiazepines as Plasmodium falciparum cytochrome bc1 inhibitors.

Authors:  Carolyn K Dong; Sameer Urgaonkar; Joseph F Cortese; Francisco-Javier Gamo; Jose F Garcia-Bustos; Maria J Lafuente; Vishal Patel; Leila Ross; Bradley I Coleman; Emily R Derbyshire; Clary B Clish; Adelfa E Serrano; Mandy Cromwell; Robert H Barker; Jeffrey D Dvorin; Manoj T Duraisingh; Dyann F Wirth; Jon Clardy; Ralph Mazitschek
Journal:  Chem Biol       Date:  2011-12-23

Review 4.  Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy.

Authors:  S R Meshnick; T E Taylor; S Kamchonwongpaisan
Journal:  Microbiol Rev       Date:  1996-06

Review 5.  Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria.

Authors:  P J de Vries; T K Dien
Journal:  Drugs       Date:  1996-12       Impact factor: 9.546

6.  Artemisinin directly targets malarial mitochondria through its specific mitochondrial activation.

Authors:  Juan Wang; Liying Huang; Jian Li; Qiangwang Fan; Yicheng Long; Ying Li; Bing Zhou
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

Review 7.  Progress in the research of artemisinin-related antimalarials: an update.

Authors:  H J Woerdenbag; N Pras; W van Uden; T E Wallaart; A C Beekman; C B Lugt
Journal:  Pharm World Sci       Date:  1994-08-05

8.  Artemisinin and a series of novel endoperoxide antimalarials exert early effects on digestive vacuole morphology.

Authors:  Maria del Pilar Crespo; Thomas D Avery; Eric Hanssen; Emma Fox; Tony V Robinson; Peter Valente; Dennis K Taylor; Leann Tilley
Journal:  Antimicrob Agents Chemother       Date:  2007-10-15       Impact factor: 5.191

9.  Yeast model uncovers dual roles of mitochondria in action of artemisinin.

Authors:  Wei Li; Weike Mo; Dan Shen; Libo Sun; Juan Wang; Shan Lu; Jane M Gitschier; Bing Zhou
Journal:  PLoS Genet       Date:  2005-09       Impact factor: 5.917

10.  Restructured Mitochondrial-Nuclear Interaction in Plasmodium falciparum Dormancy and Persister Survival after Artemisinin Exposure.

Authors:  Sean V Connelly; Javier Manzella-Lapeira; Zoë C Levine; Joseph Brzostowski; Ludmila Krymskaya; Rifat S Rahman; Angela C Ellis; Shuchi N Amin; Juliana M Sá; Thomas E Wellems
Journal:  mBio       Date:  2021-05-28       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.